• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The Name Game

The Name Game

August 21, 2006
CenterWatch Staff

It’s a call I made in January. So what took SFBC so long to decide to change its name to PharmaNet? While the move took a little longer than expected, it is another sign that new CEO Jeffrey McMullen and his PharmaNet-ters still have a solid chance to turnaround the troubled former SFBC.

CenterWatch has known that the PharmaNet name has a lot of positive brand equity. It has been a top performer among contract research organizations in the CenterWatch Survey of Investigative Sites in the US for 2005 and 2003. It was also top-rated in Europe in 2004.

CenterWatch has known that the PharmaNet name has a lot of positive brand equity. It has been a top performer among contract research organizations in the CenterWatch Survey of Investigative Sites in the US for 2005 and 2003. It was also top-rated in Europe in 2004.

Since January the company has been working through a long list of issues, but there is still much work to be done. The list was lengthy concerning its clinical trial patient recruitment practices; the departures of its former CEO, president and legal affairs head; a U.S. Senate Committee investigation; a revenue restatement; and a crumbling phase I facility in Miami. Given the bad press SFBC had received, its name had become a burden. It was time for a fresh start.

McMullen came to SFBC in December 2004 when the company bought PharmaNet as it moved out of early clinical research into phase II-IV. He took over when the SFBC’s leadership resigned under scrutiny from the press and regulators.

Some were encouraged last week when SFBC reported its backlog numbers—and also announced its name change, pending approval. Others may still want PharmaNet totally out of the early clinical business and to focus on what PharmaNet did best: phases II-IV. PharmaNet is in fact 70% of the business. Its early stages division will operate under the names Anapharm and Taylor Technology.

The name change may be the easy part. A complete turnaround is still an open question.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing